IE
IDYA icon

Israel Englander’s IDEAYA Biosciences IDYA Stock Holding History

Israel Englander’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
10,500
-218,480
-95% -$6.69M ﹤0.01% 4949
2026
Q1 		$7.63M Buy
228,980
+20,432
+10% +$685K ﹤0.01% 2458
2025
Q4 		$7.21M Buy
208,548
+70,963
+52% +$2.26M ﹤0.01% 2620
2025
Q3 		$3.74M Buy
137,585
+70,899
+106% +$1.71M ﹤0.01% 3437
2025
Q2 		$1.4M Sell
66,686
-480,951
-88% -$9.23M ﹤0.01% 4169
2025
Q1 		$8.97M Buy
547,637
+424,625
+345% +$9.05M ﹤0.01% 2296
2024
Q4 		$3.16M Sell
123,012
-219,069
-64% -$6.2M ﹤0.01% 3252
2024
Q3 		$10.8M Buy
342,081
+83,475
+32% +$3.17M 0.01% 2125
2024
Q2 		$9.08M Buy
258,606
+120,395
+87% +$4.77M ﹤0.01% 2174
2024
Q1 		$6.06M Buy
+138,211
New +$5.94M ﹤0.01% 2679
2023
Q2 		– Sell
-17,202
Closed -$236K – 6368
2023
Q1 		$236K Sell
17,202
-169,225
-91% -$2.82M ﹤0.01% 5074
2022
Q4 		$3.39M Buy
+186,427
New +$3.14M ﹤0.01% 3123
2022
Q3 		– Sell
-99,982
Closed -$1.38M – 7243
2022
Q2 		$1.38M Sell
99,982
-25,990
-21% -$289K ﹤0.01% 4069
2022
Q1 		$1.41M Buy
125,972
+102,769
+443% +$1.51M ﹤0.01% 4188
2021
Q4 		$549K Buy
23,203
+12,741
+122% +$296K ﹤0.01% 4960
2021
Q3 		$267K Sell
10,462
-112,935
-92% -$2.64M ﹤0.01% 5898
2021
Q2 		$2.59M Buy
123,397
+5,085
+4% +$104K ﹤0.01% 3632
2021
Q1 		$2.78M Buy
118,312
+32,573
+38% +$629K ﹤0.01% 3209
2020
Q4 		$1.2M Sell
85,739
-14,091
-14% -$191K ﹤0.01% 3618
2020
Q3 		$1.25K Buy
99,830
+12,090
+14% +$150K ﹤0.01% 2971
2020
Q2 		$1.25M Buy
87,740
+28,476
+48% +$224K ﹤0.01% 2856
2020
Q1 		$244K Buy
59,264
+20,572
+53% +$146K ﹤0.01% 3285
2019
Q4 		$290K Sell
38,692
-23,356
-38% -$167K ﹤0.01% 3679
2019
Q3 		$558K Buy
62,048
+18,615
+43% +$142K ﹤0.01% 3192
2019
Q2 		$433K Buy
+43,433
New +$472K ﹤0.01% 3330

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Israel Englander's IDYA Position: Q2 2026 in Review

Israel Englander reduced its IDEAYA Biosciences (IDYA) stake by 95% in Q2 2026, selling an estimated $6.69M and leaving 10,500 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #4949.

Israel Englander first reported a position in IDYA in Q2 2019 and has held it in 25 quarters since. The position peaked at $10.8M in Q3 2024. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Israel Englander held 10,500 shares of IDEAYA Biosciences worth $391K as of Q2 2026.
  • Israel Englander sold 218,480 IDEAYA Biosciences shares in Q2 2026, an estimated $6.69M.
  • IDEAYA Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4949 holding.
  • Israel Englander first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 25 quarters since.
  • Israel Englander's IDEAYA Biosciences position peaked at $10.8M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.